Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer Risk
100%
Endocrine Therapy
100%
Distant Recurrence
100%
Breast Cancer Recurrence
100%
Strong Correlation
50%
Tumor Grade
50%
Breast Cancer
33%
Absolute Risk
33%
Estrogen Receptor-positive Breast Cancer
33%
Contralateral Breast Cancer
33%
T1N0
33%
Meta-analysis
16%
Risk of Death
16%
Recurrence Rate
16%
Cox Regression Analysis
16%
Predictive Value
16%
Patient Outcomes
16%
Ki-67
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
Trastuzumab
16%
Nodal Status
16%
Kaplan-Meier
16%
Progesterone Receptor
16%
Tumor Diameter
16%
Adjuvant Endocrine Therapy
16%
Disease-free
16%
Cancer Research
16%
Nodal Involvement
16%
T2N0
16%
T1-2N1
16%
Medicine and Dentistry
Hormone Therapy
100%
Recurrent Disease
100%
Breast Cancer
100%
Disease
85%
Neoplasm
57%
Contralateral
28%
Estrogen Receptor Positive Breast Cancer
28%
Side Effect
14%
Meta-Analysis
14%
Recurrence Risk
14%
Proportional Hazards Model
14%
Epidermal Growth Factor Receptor
14%
Progesterone Receptor
14%
Trastuzumab
14%
Gamma Urogastrone
14%
Adjuvant Endocrine Therapy
14%
Cancer Research
14%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Therapy
100%
Breast Cancer
100%
Recurrent Disease
100%
Disease
85%
Neoplasm
57%
Estrogen Receptor Positive Breast Cancer
28%
Malignant Neoplasm
14%
Side Effect
14%
Recurrence Risk
14%
Trastuzumab
14%
Epidermal Growth Factor Receptor
14%
Gamma Urogastrone
14%
Progesterone Receptor
14%